Literature DB >> 26525588

Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice.

Phillipe D O'Brien1, Junguk Hur2, Nicholas J Robell3, John M Hayes1, Stacey A Sakowski4, Eva L Feldman5.   

Abstract

AIMS: To identify a female mouse model of diabetic peripheral neuropathy (DPN), we characterized DPN in female BTBR ob/ob mice and compared their phenotype to non-diabetic and gender-matched controls. We also identified dysregulated genes and pathways in sciatic nerve (SCN) and dorsal root ganglia (DRG) of female BTBR ob/ob mice to determine potential DPN mechanisms.
METHODS: Terminal neuropathy phenotyping consisted of examining latency to heat stimuli, sciatic motor and sural sensory nerve conduction velocities (NCV), and intraepidermal nerve fiber (IENF) density. For gene expression profiling, DRG and SCN were dissected, RNA was isolated and processed using microarray technology and differentially expressed genes were identified.
RESULTS: Similar motor and sensory NCV deficits were observed in male and female BTBR ob/ob mice at study termination; however, IENF density was greater in female ob/ob mice than their male counterparts. Male and female ob/ob mice exhibited similar weight gain, hyperglycemia, and hyperinsulinemia compared to non-diabetic controls, although triglycerides were elevated more so in males than in females. Transcriptional profiling of nerve tissue from female mice identified dysregulation of pathways related to inflammation.
CONCLUSIONS: Similar to males, female BTBR ob/ob mice display robust DPN, and pathways related to inflammation are dysregulated in peripheral nerve.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal models; Diabetic peripheral neuropathy; Dyslipidemia; Gene expression; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26525588      PMCID: PMC4698064          DOI: 10.1016/j.jdiacomp.2015.09.018

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  54 in total

1.  Insulin clearance is different in men and women.

Authors:  Michael D Jensen; Soren Nielsen; Nidhi Gupta; Rita Basu; Robert A Rizza
Journal:  Metabolism       Date:  2011-10-13       Impact factor: 8.694

2.  Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction.

Authors:  Rita Basu; Chiara Dalla Man; Marco Campioni; Ananda Basu; George Klee; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

3.  The identification of gene expression profiles associated with progression of human diabetic neuropathy.

Authors:  Junguk Hur; Kelli A Sullivan; Manjusha Pande; Yu Hong; Anders A F Sima; Hosagrahar V Jagadish; Matthias Kretzler; Eva L Feldman
Journal:  Brain       Date:  2011-09-16       Impact factor: 13.501

Review 4.  Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.

Authors:  Joseph P Tiano; Franck Mauvais-Jarvis
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

Review 5.  Enhanced glucose control for preventing and treating diabetic neuropathy.

Authors:  Brian C Callaghan; Ann A Little; Eva L Feldman; Richard A C Hughes
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

6.  BTBR Ob/Ob mutant mice model progressive diabetic nephropathy.

Authors:  Kelly L Hudkins; Warangkana Pichaiwong; Tomasz Wietecha; Jolanta Kowalewska; Miriam C Banas; Min W Spencer; Anja Mühlfeld; Mariko Koelling; Jeffrey W Pippin; Stuart J Shankland; Bardia Askari; Mary E Rabaglia; Mark P Keller; Alan D Attie; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 10.121

7.  Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

Authors:  Andrea M Vincent; John M Hayes; Lisa L McLean; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Eva L Feldman
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

8.  Obesity and hyperlipidemia are risk factors for early diabetic neuropathy.

Authors:  A Gordon Smith; J Robinson Singleton
Journal:  J Diabetes Complications       Date:  2013-06-02       Impact factor: 2.852

9.  Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.

Authors:  Manjusha Pande; Junguk Hur; Yu Hong; Carey Backus; John M Hayes; Sang Su Oh; Matthias Kretzler; Eva L Feldman
Journal:  Diabetes       Date:  2011-05-26       Impact factor: 9.461

10.  Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy.

Authors:  Carol Forsblom; Anne Hiukka; Eeva S Leinonen; Jouko Sundvall; Per-Henrik Groop; Marja-Riitta Taskinen
Journal:  Diabetes Care       Date:  2009-10-21       Impact factor: 19.112

View more
  17 in total

Review 1.  New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.

Authors:  Eva L Feldman; Klaus-Armin Nave; Troels S Jensen; David L H Bennett
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

Review 2.  Schwann cell interactions with axons and microvessels in diabetic neuropathy.

Authors:  Nádia P Gonçalves; Christian B Vægter; Henning Andersen; Leif Østergaard; Nigel A Calcutt; Troels S Jensen
Journal:  Nat Rev Neurol       Date:  2017-01-30       Impact factor: 42.937

Review 3.  Neuroactive Steroids and Sex-Dimorphic Nervous Damage Induced by Diabetes Mellitus.

Authors:  Silvia Giatti; Silvia Diviccaro; Roberto Cosimo Melcangi
Journal:  Cell Mol Neurobiol       Date:  2018-08-14       Impact factor: 5.046

4.  Effect of Experimental Gestational Diabetes Mellitus on Mechanical Sensitivity, Capsaicin-Induced Pain Behaviors and Hind Paw Glabrous Skin Innervation of Male and Female Mouse Offspring.

Authors:  Enriqueta Munoz-Islas; Cecilia Esther Elizondo-Martinez; Mariela Gutierrez-Lopez; Rosa Issel Acosta-Gonzalez; Veronica Zaga-Clavellina; Addy Cecilia Helguera-Repetto; Martha Beatriz Ramirez-Rosas; E Alfonso Romero-Sandoval; Juan Miguel Jimenez-Andrade
Journal:  J Pain Res       Date:  2021-06-02       Impact factor: 3.133

5.  Sensory and autonomic function and structure in footpads of a diabetic mouse model.

Authors:  Ying Liu; Blessan Sebastian; Ben Liu; Yiyue Zhang; John A Fissel; Baohan Pan; Michael Polydefkis; Mohamed H Farah
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

6.  Axonal transport in a peripheral diabetic neuropathy model: sex-dimorphic features.

Authors:  Marzia Pesaresi; Silvia Giatti; Roberto Spezzano; Simone Romano; Silvia Diviccaro; Tiziana Borsello; Nico Mitro; Donatella Caruso; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  Biol Sex Differ       Date:  2018-01-19       Impact factor: 5.027

Review 7.  Susceptible and Prognostic Genetic Factors Associated with Diabetic Peripheral Neuropathy: A Comprehensive Literature Review.

Authors:  L B L Prabodha; N D Sirisena; V H W Dissanayake
Journal:  Int J Endocrinol       Date:  2018-03-15       Impact factor: 3.257

8.  Obesity-induced metabolic disturbance drives oxidative stress and complement activation in the retinal environment.

Authors:  Riccardo Natoli; Nilisha Fernando; Tess Dahlenburg; Haihan Jiao; Riemke Aggio-Bruce; Nigel L Barnett; Juan Manuel Chao de la Barca; Guillaume Tcherkez; Pascal Reynier; Johnny Fang; Joshua A Chu-Tan; Krisztina Valter; Jan Provis; Matt Rutar
Journal:  Mol Vis       Date:  2018-03-07       Impact factor: 2.367

9.  Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy.

Authors:  Brett A McGregor; Stephanie Eid; Amy E Rumora; Benjamin Murdock; Kai Guo; Guillermo de Anda-Jáuregui; James E Porter; Eva L Feldman; Junguk Hur
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

10.  Determination of peripheral neuropathy in high-fat diet fed low-dose streptozotocin-treated female C57Bl/6J mice and Sprague-Dawley rats.

Authors:  Lawrence J Coppey; Hanna Shevalye; Alexander Obrosov; Eric P Davidson; Mark A Yorek
Journal:  J Diabetes Investig       Date:  2018-03-25       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.